678668
OraLabs, Incorporated — FEI 3001237145
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 11, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Parker, CO (United States)
Citations
| ID | CFR | Description |
| 1133 | 21 CFR 211.25(a) | GMP Training Frequency |
| 1274 | 21 CFR 211.68(a) | Calibration/Inspection/Checking not done |
| 1809 | 21 CFR 211.160(a) | Following/documenting laboratory controls |
| 1883 | 21 CFR 211.165(a) | Testing and release for distribution |
| 2009 | 21 CFR 211.188 | Prepared for each batch, include complete information |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2203 | 21 CFR 211.186(b)(7) | Theoretical Yield and Percentages |
| 3571 | 21 CFR 211.100(a) | Changes to Procedures Not Reviewed, Approved |
| 3585 | 21 CFR 211.110(a) | Control procedures to monitor and validate performance |
| 3639 | 21 CFR 211.204 | Returned drug procedures in writing and followed |
| 4387 | 21 CFR 211.198(a) | Reporting of adverse drug experience to FDA |